Surmodics, Inc. (SRDX)

37.23 +0.30 (+0.81%) At close: 04:00PM EDT

Surmodics, Inc.

9924 West 74th Street
Eden Prairie, MN 55344-3523
United States
952 500 7000
https://www.surmodics.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 389

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Gary R. Maharaj	CEO, Pres & Director	1.29M	2.59M	1963
Mr. Timothy J. Arens	Sr. VP of Fin. & Information Technology and CFO	572k	857.12k	1967
Mr. Gordon S. Weber	Sr. VP of Legal, Gen. Counsel & Sec.	573.67k	N/A	1963
Ms. Teryl L. W. Sides	Sr. VP of Product Devel. & Chief Marketing Officer	638.67k	N/A	1970
Mr. Joseph J. Stich	Sr. VP and GM of HR & In Vitro Diagnostics	570.92k	501.23k	1965
Mr. John D. Manders	Corp. Controller & Principal Accounting Officer	N/A	N/A	1981
Mr. Charles W. Olson	Sr. VP of Commercial & Bus. Devel. of Medical Devices	N/A	N/A	1964
Mr. Gregg S. Sutton	VP of R&D - Medical Devices	N/A	N/A	1960

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

Corporate Governance

Surmodics, Inc.’s ISS Governance QualityScore as of May 1, 2022 is 2. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 5; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.